Pharmacoeconomic implications of preference toward reference- versus generic-brand antidepressants in primary care

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGultekin, Onur
dc.contributor.authorAydin, Volkan
dc.contributor.authorBayram, Dilara
dc.contributor.authorAtac, Omer
dc.contributor.authorAkici, Ahmet
dc.date.accessioned2025-10-16T15:12:41Z
dc.date.issued2024
dc.identifier.doi10.1017/S1463423624000276
dc.identifier.otherWOS:001316034500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5566
dc.publisherCAMBRIDGE UNIV PRESS
dc.sourcePRIMARY HEALTH CARE RESEARCH \& DEVELOPMENT
dc.subjectantidepressive agents
dc.subjectdrug utilization
dc.subjectgeneric drugs
dc.subjectpharmacoeconomics
dc.subjectprimary health care
dc.titlePharmacoeconomic implications of preference toward reference- versus generic-brand antidepressants in primary care
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS